The 3D bioprinting market had a global size of USD 1.27 Billion in 2022, with an expected growth to USD 10.35 Billion by 2032, and a projected revenue compound annual growth rate (CAGR) of 26.2% during the forecast period. Market growth is primarily driven by factors such as the increasing demand for organ transplants, the expanding utilization of 3D bioprinting in the pharmaceutical and biotechnology industries, and advancements in 3D printing technology. https://www.reportsanddata.com..../report-detail/3d-bi
Мне нравится
Комментарий
Перепост
